Long-term Follow-up to the Phase 1 Study of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine for COVID-19.
Clinical trial NCT04932824 · COMPLETED
Trial details
- NCT number
- NCT04932824
- Sponsor
- Clover Biopharmaceuticals AUS Pty
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-19
- Primary completion
- 2021-11-10
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.